IRB Meeting Schedule and Submission Deadlines
The IRB meets quarterly in February, April, September, and November (twice per semester) to discuss routine business and to review protocols that may require Full Board Reviews. The corresponding submission schedule posted below, outlines when protocols need to be submitted in order to be reviewed by the Full Board for the next scheduled meeting.
IRB meetings are considered closed-sessions and attendance to convened meetings are through invitation or otherwise approved by the committee Chair.
IRB meetings are considered closed-sessions and attendance to convened meetings are through invitation or otherwise approved by the committee Chair.
IRB
|
IRB Protocols or Renewal Requests Requiring Full Board Review Submission Deadline |
IRB Protocols Not Expected to Require Full Board Review Submission Deadline |
Modifications to and Closures of Approved Protocol Submittals |
| September 11, 2023 |
September 14, 2023 |
September 14, 2023 |
September 14, 2023 |
|
October 6, 2023 |
September 15, 2023 |
September 15, 2023 |
September 15, 2023 |
|
October 27, 2023 |
September 29, 2023 |
September 29, 2023 |
September 29, 2023 |
|
December 1, 2023 |
November 9, 2023 |
November 9, 2023 |
November 9, 2023 |
|
February 2, 2024 |
January 5, 2024 | January 5, 2024 | January 5, 2024 |
|
March 1, 2024 |
February 9, 2024 | February 9, 2024 | February 9, 2024 |
|
April 12, 2024 |
April 8, 2024 | April 8, 2024 | April 8, 2024 |
Protocol Categorizations
IRB Protocols or Renewal Requests Requiring Full Board Review |
Non-Exempt Protocols that include more than minor risk to study participants or non-participants, including vulnerable populations, or that are complex or otherwise warrant full-board review. |
IRB Protocols Not Expected to Require Full Board Review |
Protocols of minimal risk to study participants and non-participants or that are likely to be found to be Exempt.
|
Modifications to and Closures of Approved Protocol
|
Modifications to request changes to study participant populations, research team members, human subject activity methodology or other changes to the original protocol.
|